PEG-derivative effectively modifies the characteristics of indomethacin-PLGA microspheres destined to intra-articular administration

References

• Blanco-Prieto MJ, Besseghir K, Zerbe O, Andris D, Orsolini F, Heingartiner P, Merkle HP, Gander B. In vitro and in vivo evaluation of a somatostatin analogue released from PLGA microspheres. Journal of Controlled Release 2000; 67: 19–28
   PubMed Web of Science ®Google Scholar
• Capsoni F, Sarzi-Puttini P, Atzeri F, Minonzio F, Bonara P, Doria A, Carraba M. Effect of adalimumad on neutrofil function in patients with rheumatoid arthritis. Arthritis Research and Therapy 2005; 7: R250–R255
   Google Scholar
• Choi Y, Kim SY, Kim SH, Lee KS, Kim C, Byun Y. Long-term delivery of all-trans-retinoic acid using biodegradable PLLA/PEG-PLLA blended microspheres. International Journal of Pharmaceutics 2001; 215: 67–81
   PubMed Web of Science ®Google Scholar
• Elmquist WF, Keith KH, Sawchuk RJ. Transsynovial drug distribution: Synovial mean transit time of diclofenac and other nonsteroidal antiinflammatory drugs. Pharmaceutical Research 1994; 11: 1689–1699
   PubMed Web of Science ®Google Scholar
• Fernández-Carballido A, Herrero-Vanrell R, Molina-Martínez IT, Pastoriza P. Sterilizad ibuprofen-loaded poly(D,L-lactide-co-glycolide) microspheres for intraarticular administration: Effect of γ-irradiation and storage. Journal of Microencapsulation 2004a; 21: 653–665
   PubMed Web of Science ®Google Scholar
• Fernández-Carballido A, Herrero-Vanrell R, Molina-Martínez IT, Pastoriza P. Biodegradable ibuprofen loaded PLGA microspheres for intraarticular administration. Effect of Labrafil addition on release in vitro. International Journal of Pharmaceutics 2004b; 27: 33–41
   Google Scholar
• Fini A, Rodriguez L, Cavallari C, Albertini B, Passerini N. Utrasound-compacted and spray-congealed indomethacin/polyethyleneglycol systems. International Journal of Pharmaceutics 2002; 247: 11–22
   PubMed Web of Science ®Google Scholar
• Gao Z, Crowley WR, Shukla AJ, Johnson JR, Reger JF. Controlled release of contraceptive steroids from biodegradable and injectable gel formulations: In vivo evaluation. Pharmaceutical Research 1995; 12: 864–868
   PubMed Web of Science ®Google Scholar
• Gasparini G, Longo R, Sarmiento R, Morabito A. Inhibitors of cyclooxygenase 2: A new class of anticancer agents?. Oncology 2003; 4: 605–615
   PubMed Web of Science ®Google Scholar
• Ghosh AK, Hirasawa N, Niki H, Ohuchi K. Cyclooxygenase-2-mediated angiogenesis in carrageenin-induced granulation tissue in rats. Journal of Pharmacology and Experimental Therapeutics 2000; 295: 802–809
   PubMed Web of Science ®Google Scholar
• Hedberg EL, Tang A, Crowther RS, Carney DH, Mikos A. Controlled release of an osteogenic peptide from injectable biodegradable polymeric composites. Journal of Controlled Release 2002; 84: 137–150
   PubMed Web of Science ®Google Scholar
• Herrero-Vanrell R, Ramírez L, Fernández-Carballido A, Refojo MF. Biodegradable PLGA microspheres loaded with Ganciclovir for intraocular administration Encapsulation technique, in-vitro release profiles, and sterilization process. Pharmaceutical Research 2000; 17: 1323–1328
   PubMed Web of Science ®Google Scholar
• Iñiguez MA, Rodriguez A, Volpert O, Fresno M, Redondo JM. Cyclooxygenase-2: A therapeutic target in angiogenesis. Trends in Molecular Medicine 2003; 9: 73–78
   PubMed Web of Science ®Google Scholar
• Karasulu E, Karasulu HY, Ertan G, Kirilmaz L, Güneri T. Extended release lipophilic indomethacin microspheres: Formulation factors and mathematical equation fitted drug release rate. European Journal of Pharmaceutical Science 2003; 19: 99–104
   PubMed Web of Science ®Google Scholar
• Kim JH, Choi HK. Effect of additives on the crystallization and the permeation of ketoprofen from adhesive matrix. International Journal of Pharmaceutics 2002; 236: 81–85
   PubMed Web of Science ®Google Scholar
• Lemaire V, Belair J, Hildgen P. Structural modelling of drug release from biodegradable porous matrices based on a combined diffusion/erosion process. International Journal of Pharmaceutics 2003; 258: 95–107
   PubMed Web of Science ®Google Scholar
• Li G, Yang T, Yan J. Cyclooxygenase-2 increased the angiogenic and metastatic potential of tumour cells. Biochemical and Biophysical Research Communications 2002; 299: 886–890
   PubMed Web of Science ®Google Scholar
• Lin SY, Chen KS, Teng HH, Li MJ. In vitro degradation and dissolution behaviours of microspheres prepared by three low molecular weight polyesters. Journal of Microencapsulation 2000; 17: 577–586
   PubMed Web of Science ®Google Scholar
• Mallard C, Coudane J, Rault I, Vert M. The use of additives to modulate the release of sparingly water soluble drug entrapped in PLA50 microparticles. Journal of Microencapsulation 2000; 17: 81–93
   PubMed Web of Science ®Google Scholar
• Martinez-Sancho C, Herrero-Vanrell R, Negro S. Optimisation of aciclovir poly (D,L-lactide-co-glycolide) microspheres for intravitreal administration using a factorial design study. International Journal of Pharmaceutics 2004; 273: 45–56
   PubMed Web of Science ®Google Scholar
• Martinez-Sancho C, Herrero-Vanrell R, Negro S. Poly (D, L, lactide-co-glycolide) microspheres for long-term intravitreal delivery of aciclovir: Influence of fatty and non fatty additives. Journal of Microencapsulation 2003; 20: 799–810
   PubMed Web of Science ®Google Scholar
• Ruan G, Feng S. Preparation and characterization of poly(lactic-acid)-polyethy(eneglycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel. Biomaterials 2003; 24: 5037–5044
   PubMed Web of Science ®Google Scholar
• Sales KJ, Katz AA, Howard B, Soeters RP, Millar RP, Jabbour HN. Cyclooxygenase-1 is upregulated in cervical carcinomas. Autocrine/paracrine regulation of cyclooxygenase-2, prostaglandin E receptors, and antiangiogenic factors by cyclooxygenase-1. Cancer Research 2002; 62: 424–432
   Google Scholar
• Sato Y, Kawashima Y, Takeuchi H, Yamamoto H. In vitro evaluation of floating and drug releasing behaviors of hollow microspheres (microballoons) prepared by emulsion solvent diffusion method. European Journal of Pharmaceutics and Biopharmaceutics 2004; 57: 235–243
   PubMed Web of Science ®Google Scholar
• Siepmann J, Peppas NA. Hydrophilic matrices for controlled drug delivery: An improved mathematical model to predict the resulting drug release kinetics (the ‘sequential layer’ model). Pharmaceutical Research 2000; 17: 1290–1298
   PubMed Web of Science ®Google Scholar
• Steinmeyer J. Pharmacotherapy in osteoarthritis. Orthopade 2001; 30: 856–865
   PubMed Web of Science ®Google Scholar
• Suzuki N, Takahashi S, Okade S. Relationship between vascular endothelial growth factor and angiogenesis in spontaneous and indomethacin-delayed healing of acetic acid-induced gastric ulcer in rats. Journal of Physiology and Pharmacology 1998; 49: 515–527
   PubMed Web of Science ®Google Scholar
• Terada K, Kitano H, Yoshihashi Y, Yonemochi E. Quantitative correlation between initial dissolution rate and heat of solution of drug. Pharmaceutical Research 2000; 17: 920–924
   PubMed Web of Science ®Google Scholar
• Tokuda J, Harada A, Hirade K, Matsuno H, Ito H, Kato K, Oiso Y, Kuzawa O. Incadronate amplifies prostaglandin F2α-induced vascular endhotelial growth factor synthesis in osteoblasts. Enhancement of MAPK activity. Journal of Biological Chemistry 2003; 278: 18930–18937
   PubMed Web of Science ®Google Scholar
• Tunçay M, Calis S, Kas HS, Ercan MT, Peksoy I, Hincal AA. Diclofenac sodium incorporated PLGA (50:50) microspheres: Formulations considerations and in vitro/in vivo evaluation. International Journal of Pharmaceutics 2000; 17: 179–188
   Google Scholar
• Villaseñor-Garcia MM, Puebla-Perez AM, Sandoval-Ramirez L, Lozoya X. Phenytoin and electric shock-induced apoptosis in rat peripheral blood lymphocytes. International Journal of Immunopharmacology 2000; 22: 143–150
   PubMed Web of Science ®Google Scholar